1 Rhinovirus Infections Drug Market Overview 1.1 Rhinovirus Infections Drug Product Scope 1.2 Rhinovirus Infections Drug Segment by Type 1.2.1 Global Rhinovirus Infections Drug Sales by Type (2016 & 2021 & 2027) 1.2.2 Cetylpyridinium Chloride 1.2.3 Human Rhinovirus (polyvalent) Vaccine 1.2.4 KR-22809 1.2.5 Others 1.3 Rhinovirus Infections Drug Segment by Application 1.3.1 Global Rhinovirus Infections Drug Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Rhinovirus Infections Drug Market Estimates and Forecasts (2016-2027) 1.4.1 Global Rhinovirus Infections Drug Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Rhinovirus Infections Drug Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Rhinovirus Infections Drug Price Trends (2016-2027) 2 Rhinovirus Infections Drug Estimates and Forecasts by Region 2.1 Global Rhinovirus Infections Drug Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Rhinovirus Infections Drug Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Rhinovirus Infections Drug Sales Market Share by Region (2016-2021) 2.2.2 Global Rhinovirus Infections Drug Revenue Market Share by Region (2016-2021) 2.3 Global Rhinovirus Infections Drug Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Rhinovirus Infections Drug Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Rhinovirus Infections Drug Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Rhinovirus Infections Drug Estimates and Projections (2016-2027) 2.4.2 Europe Rhinovirus Infections Drug Estimates and Projections (2016-2027) 2.4.3 China Rhinovirus Infections Drug Estimates and Projections (2016-2027) 2.4.4 Japan Rhinovirus Infections Drug Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Rhinovirus Infections Drug Estimates and Projections (2016-2027) 2.4.6 India Rhinovirus Infections Drug Estimates and Projections (2016-2027) 3 Global Rhinovirus Infections Drug Competition Landscape by Players 3.1 Global Top Rhinovirus Infections Drug Players by Sales (2016-2021) 3.2 Global Top Rhinovirus Infections Drug Players by Revenue (2016-2021) 3.3 Global Rhinovirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rhinovirus Infections Drug as of 2020) 3.4 Global Rhinovirus Infections Drug Average Price by Company (2016-2021) 3.5 Manufacturers Rhinovirus Infections Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Rhinovirus Infections Drug Market Size by Type 4.1 Global Rhinovirus Infections Drug Historic Market Review by Type (2016-2021) 4.1.1 Global Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) 4.1.2 Global Rhinovirus Infections Drug Revenue Market Share by Type (2016-2021) 4.1.3 Global Rhinovirus Infections Drug Price by Type (2016-2021) 4.2 Global Rhinovirus Infections Drug Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Rhinovirus Infections Drug Sales Forecast by Type (2022-2027) 4.2.2 Global Rhinovirus Infections Drug Revenue Forecast by Type (2022-2027) 4.2.3 Global Rhinovirus Infections Drug Price Forecast by Type (2022-2027) 5 Global Rhinovirus Infections Drug Market Size by Application 5.1 Global Rhinovirus Infections Drug Historic Market Review by Application (2016-2021) 5.1.1 Global Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) 5.1.2 Global Rhinovirus Infections Drug Revenue Market Share by Application (2016-2021) 5.1.3 Global Rhinovirus Infections Drug Price by Application (2016-2021) 5.2 Global Rhinovirus Infections Drug Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Rhinovirus Infections Drug Sales Forecast by Application (2022-2027) 5.2.2 Global Rhinovirus Infections Drug Revenue Forecast by Application (2022-2027) 5.2.3 Global Rhinovirus Infections Drug Price Forecast by Application (2022-2027) 6 North America Rhinovirus Infections Drug Market Facts & Figures 6.1 North America Rhinovirus Infections Drug Sales by Company 6.1.1 North America Rhinovirus Infections Drug Sales by Company (2016-2021) 6.1.2 North America Rhinovirus Infections Drug Revenue by Company (2016-2021) 6.2 North America Rhinovirus Infections Drug Sales Breakdown by Type 6.2.1 North America Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 6.2.2 North America Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 6.3 North America Rhinovirus Infections Drug Sales Breakdown by Application 6.3.1 North America Rhinovirus Infections Drug Sales Breakdown by Application (2016-2021) 6.3.2 North America Rhinovirus Infections Drug Sales Breakdown by Application (2022-2027) 7 Europe Rhinovirus Infections Drug Market Facts & Figures 7.1 Europe Rhinovirus Infections Drug Sales by Company 7.1.1 Europe Rhinovirus Infections Drug Sales by Company (2016-2021) 7.1.2 Europe Rhinovirus Infections Drug Revenue by Company (2016-2021) 7.2 Europe Rhinovirus Infections Drug Sales Breakdown by Type 7.2.1 Europe Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 7.2.2 Europe Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 7.3 Europe Rhinovirus Infections Drug Sales Breakdown by Application 7.3.1 Europe 121 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 121 Sales Breakdown by Application (2022-2027) 8 China Rhinovirus Infections Drug Market Facts & Figures 8.1 China Rhinovirus Infections Drug Sales by Company 8.1.1 China Rhinovirus Infections Drug Sales by Company (2016-2021) 8.1.2 China Rhinovirus Infections Drug Revenue by Company (2016-2021) 8.2 China Rhinovirus Infections Drug Sales Breakdown by Type 8.2.1 China Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 8.2.2 China Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 8.3 China Rhinovirus Infections Drug Sales Breakdown by Application 8.3.1 China 142 Sales Breakdown by Application (2016-2021) 8.3.2 China 142 Sales Breakdown by Application (2022-2027) 9 Japan Rhinovirus Infections Drug Market Facts & Figures 9.1 Japan Rhinovirus Infections Drug Sales by Company 9.1.1 Japan Rhinovirus Infections Drug Sales by Company (2016-2021) 9.1.2 Japan Rhinovirus Infections Drug Revenue by Company (2016-2021) 9.2 Japan Rhinovirus Infections Drug Sales Breakdown by Type 9.2.1 Japan Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 9.2.2 Japan Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 9.3 Japan Rhinovirus Infections Drug Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Rhinovirus Infections Drug Market Facts & Figures 10.1 Southeast Asia Rhinovirus Infections Drug Sales by Company 10.1.1 Southeast Asia Rhinovirus Infections Drug Sales by Company (2016-2021) 10.1.2 Southeast Asia Rhinovirus Infections Drug Revenue by Company (2016-2021) 10.2 Southeast Asia Rhinovirus Infections Drug Sales Breakdown by Type 10.2.1 Southeast Asia Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Rhinovirus Infections Drug Sales Breakdown by Application 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027) 11 India Rhinovirus Infections Drug Market Facts & Figures 11.1 India Rhinovirus Infections Drug Sales by Company 11.1.1 India Rhinovirus Infections Drug Sales by Company (2016-2021) 11.1.2 India Rhinovirus Infections Drug Revenue by Company (2016-2021) 11.2 India Rhinovirus Infections Drug Sales Breakdown by Type 11.2.1 India Rhinovirus Infections Drug Sales Breakdown by Type (2016-2021) 11.2.2 India Rhinovirus Infections Drug Sales Breakdown by Type (2022-2027) 11.3 India Rhinovirus Infections Drug Sales Breakdown by Application 11.3.1 India Rhinovirus Infections Drug Sales Breakdown by Application (2016-2021) 11.3.2 India Rhinovirus Infections Drug Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Rhinovirus Infections Drug Business 12.1 AIMM Therapeutics B.V. 12.1.1 AIMM Therapeutics B.V. Corporation Information 12.1.2 AIMM Therapeutics B.V. Business Overview 12.1.3 AIMM Therapeutics B.V. Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AIMM Therapeutics B.V. Rhinovirus Infections Drug Products Offered 12.1.5 AIMM Therapeutics B.V. Recent Development 12.2 Biological Mimetics, Inc. 12.2.1 Biological Mimetics, Inc. Corporation Information 12.2.2 Biological Mimetics, Inc. Business Overview 12.2.3 Biological Mimetics, Inc. Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Biological Mimetics, Inc. Rhinovirus Infections Drug Products Offered 12.2.5 Biological Mimetics, Inc. Recent Development 12.3 Biota Pharmaceuticals, Inc. 12.3.1 Biota Pharmaceuticals, Inc. Corporation Information 12.3.2 Biota Pharmaceuticals, Inc. Business Overview 12.3.3 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Products Offered 12.3.5 Biota Pharmaceuticals, Inc. Recent Development 12.4 Boehringer Ingelheim GmbH 12.4.1 Boehringer Ingelheim GmbH Corporation Information 12.4.2 Boehringer Ingelheim GmbH Business Overview 12.4.3 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Products Offered 12.4.5 Boehringer Ingelheim GmbH Recent Development 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Corporation Information 12.5.2 Johnson & Johnson Business Overview 12.5.3 Johnson & Johnson Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Johnson & Johnson Rhinovirus Infections Drug Products Offered 12.5.5 Johnson & Johnson Recent Development 12.6 Novartis AG 12.6.1 Novartis AG Corporation Information 12.6.2 Novartis AG Business Overview 12.6.3 Novartis AG Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Novartis AG Rhinovirus Infections Drug Products Offered 12.6.5 Novartis AG Recent Development 12.7 Theraclone Sciences, Inc. 12.7.1 Theraclone Sciences, Inc. Corporation Information 12.7.2 Theraclone Sciences, Inc. Business Overview 12.7.3 Theraclone Sciences, Inc. Rhinovirus Infections Drug Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Theraclone Sciences, Inc. Rhinovirus Infections Drug Products Offered 12.7.5 Theraclone Sciences, Inc. Recent Development ... 13 Rhinovirus Infections Drug Manufacturing Cost Analysis 13.1 Rhinovirus Infections Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Rhinovirus Infections Drug 13.4 Rhinovirus Infections Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Rhinovirus Infections Drug Distributors List 14.3 Rhinovirus Infections Drug Customers 15 Market Dynamics 15.1 Rhinovirus Infections Drug Market Trends 15.2 Rhinovirus Infections Drug Drivers 15.3 Rhinovirus Infections Drug Market Challenges 15.4 Rhinovirus Infections Drug Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Rhinovirus Infections Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Rhinovirus Infections Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Rhinovirus Infections Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Rhinovirus Infections Drug Sales (K Pcs) by Region (2016-2021) Table 5. Global Rhinovirus Infections Drug Sales Market Share by Region (2016-2021) Table 6. Global Rhinovirus Infections Drug Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Rhinovirus Infections Drug Revenue Share by Region (2016-2021) Table 8. Global Rhinovirus Infections Drug Sales (K Pcs) Forecast by Region (2022-2027) Table 9. Global Rhinovirus Infections Drug Sales Market Share Forecast by Region (2022-2027) Table 10. Global Rhinovirus Infections Drug Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Rhinovirus Infections Drug Revenue Share Forecast by Region (2022-2027) Table 12. Global Rhinovirus Infections Drug Sales (K Pcs) of Key Companies (2016-2021) Table 13. Global Rhinovirus Infections Drug Sales Share by Company (2016-2021) Table 14. Global Rhinovirus Infections Drug Revenue (US$ Million) by Company (2016-2021) Table 15. Global Rhinovirus Infections Drug Revenue Share by Company (2016-2021) Table 16. Global Rhinovirus Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rhinovirus Infections Drug as of 2020) Table 17. Global Rhinovirus Infections Drug Average Price (USD/Pcs) of Key Company (2016-2021) Table 18. Manufacturers Rhinovirus Infections Drug Manufacturing Sites and Area Served Table 19. Manufacturers Rhinovirus Infections Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Rhinovirus Infections Drug Sales (K Pcs) by Type (2016-2021) Table 22. Global Rhinovirus Infections Drug Sales Share by Type (2016-2021) Table 23. Global Rhinovirus Infections Drug Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Rhinovirus Infections Drug Price (USD/Pcs) by Type (2016-2021) Table 25. Global Rhinovirus Infections Drug Sales Share by Type (2022-2027) Table 26. Global Rhinovirus Infections Drug Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Rhinovirus Infections Drug Revenue Share by Type (2022-2027) Table 28. Global Rhinovirus Infections Drug Price (USD/Pcs) by Type (2022-2027) Table 29. Global Rhinovirus Infections Drug Sales (K Pcs) by Application (2016-2021) Table 30. Global Rhinovirus Infections Drug Sales Share by Application (2016-2021) Table 31. Global Rhinovirus Infections Drug Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Rhinovirus Infections Drug Price (USD/Pcs) by Application (2016-2021) Table 33. Global Rhinovirus Infections Drug Sales (K Pcs) by Application (2022-2027) Table 34. Global Rhinovirus Infections Drug Sales Share by Application (2022-2027) Table 35. Global Rhinovirus Infections Drug Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Rhinovirus Infections Drug Revenue Share by Application (2022-2027) Table 37. Global Rhinovirus Infections Drug Price (USD/Pcs) by Application (2022-2027) Table 38. North America Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 39. North America Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 40. North America Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 42. North America Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 43. North America Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 44. North America Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 45. North America Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 46. North America Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 47. North America Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 48. North America Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 49. North America Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 50. Europe Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 51. Europe Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 52. Europe Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 54. Europe Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 55. Europe Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 56. Europe Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 57. Europe Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 58. Europe Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 59. Europe Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 60. Europe Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 61. Europe Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 62. China Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 63. China Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 64. China Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 65. China Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 66. China Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 67. China Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 68. China Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 69. China Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 70. China Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 71. China Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 72. China Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 73. China Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 74. Japan Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 75. Japan Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 76. Japan Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 78. Japan Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 79. Japan Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 80. Japan Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 81. Japan Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 82. Japan Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 83. Japan Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 84. Japan Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 85. Japan Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 87. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 91. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 93. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 95. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 97. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 98. India Rhinovirus Infections Drug Sales (K Pcs) by Company (2016-2021) Table 99. India Rhinovirus Infections Drug Sales Market Share by Company (2016-2021) Table 100. India Rhinovirus Infections Drug Revenue by Company (2016-2021) & (US$ Million) Table 101. India Rhinovirus Infections Drug Revenue Market Share by Company (2016-2021) Table 102. India Rhinovirus Infections Drug Sales by Type (2016-2021) & (K Pcs) Table 103. India Rhinovirus Infections Drug Sales Market Share by Type (2016-2021) Table 104. India Rhinovirus Infections Drug Sales by Type (2022-2027) & (K Pcs) Table 105. India Rhinovirus Infections Drug Sales Market Share by Type (2022-2027) Table 106. India Rhinovirus Infections Drug Sales by Application (2016-2021) & (K Pcs) Table 107. India Rhinovirus Infections Drug Sales Market Share by Application (2016-2021) Table 108. India Rhinovirus Infections Drug Sales by Application (2022-2027) & (K Pcs) Table 109. India Rhinovirus Infections Drug Sales Market Share by Application (2022-2027) Table 110. AIMM Therapeutics B.V. Corporation Information Table 111. AIMM Therapeutics B.V. Description and Business Overview Table 112. AIMM Therapeutics B.V. Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. AIMM Therapeutics B.V. Rhinovirus Infections Drug Product Table 114. AIMM Therapeutics B.V. Recent Development Table 115. Biological Mimetics, Inc. Corporation Information Table 116. Biological Mimetics, Inc. Description and Business Overview Table 117. Biological Mimetics, Inc. Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. Biological Mimetics, Inc. Rhinovirus Infections Drug Product Table 119. Biological Mimetics, Inc. Recent Development Table 120. Biota Pharmaceuticals, Inc. Corporation Information Table 121. Biota Pharmaceuticals, Inc. Description and Business Overview Table 122. Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Product Table 124. Biota Pharmaceuticals, Inc. Recent Development Table 125. Boehringer Ingelheim GmbH Corporation Information Table 126. Boehringer Ingelheim GmbH Description and Business Overview Table 127. Boehringer Ingelheim GmbH Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Boehringer Ingelheim GmbH Rhinovirus Infections Drug Product Table 129. Boehringer Ingelheim GmbH Recent Development Table 130. Johnson & Johnson Corporation Information Table 131. Johnson & Johnson Description and Business Overview Table 132. Johnson & Johnson Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. Johnson & Johnson Rhinovirus Infections Drug Product Table 134. Johnson & Johnson Recent Development Table 135. Novartis AG Corporation Information Table 136. Novartis AG Description and Business Overview Table 137. Novartis AG Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. Novartis AG Rhinovirus Infections Drug Product Table 139. Novartis AG Recent Development Table 140. Theraclone Sciences, Inc. Corporation Information Table 141. Theraclone Sciences, Inc. Description and Business Overview Table 142. Theraclone Sciences, Inc. Rhinovirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Theraclone Sciences, Inc. Rhinovirus Infections Drug Product Table 144. Theraclone Sciences, Inc. Recent Development Table 145. Production Base and Market Concentration Rate of Raw Material Table 146. Key Suppliers of Raw Materials Table 147. Rhinovirus Infections Drug Distributors List Table 148. Rhinovirus Infections Drug Customers List Table 149. Rhinovirus Infections Drug Market Trends Table 150. Rhinovirus Infections Drug Market Drivers Table 151. Rhinovirus Infections Drug Market Challenges Table 152. Rhinovirus Infections Drug Market Restraints Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Rhinovirus Infections Drug Product Picture Figure 2. Global Rhinovirus Infections Drug Sales Market Share by Type in 2021 & 2027 Figure 3. Cetylpyridinium Chloride Product Picture Figure 4. Human Rhinovirus (polyvalent) Vaccine Product Picture Figure 5. KR-22809 Product Picture Figure 6. Others Product Picture Figure 7. Global Rhinovirus Infections Drug Sales Market Share by Application in 2021 & 2027 Figure 8. Clinic Examples Figure 9. Hospital Examples Figure 10. Others Examples Figure 11. Global Rhinovirus Infections Drug Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Rhinovirus Infections Drug Sales Growth Rate (2016-2027) & (US$ Million) Figure 13. Global Rhinovirus Infections Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 14. Global Rhinovirus Infections Drug Price Trends Growth Rate (2016-2027) (USD/Pcs) Figure 15. Global Rhinovirus Infections Drug Revenue Market Share by Region: 2016 VS 2021 Figure 16. Global Rhinovirus Infections Drug Revenue Market Share by Region: 2021 VS 2027 Figure 17. North America Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 18. North America Rhinovirus Infections Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 19. Europe Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 20. Europe Rhinovirus Infections Drug Sales (Million USD) Growth Rate (2016-2027) Figure 21. China Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 22. China Rhinovirus Infections Drug Sales (Million USD) and Growth Rate (2016-2027) Figure 23. Japan Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Japan Rhinovirus Infections Drug Sales (Million USD) Growth Rate (2016-2027) Figure 25. Southeast Asia Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 26. Southeast Asia Rhinovirus Infections Drug Sales (Million USD) Growth Rate (2016-2027) Figure 27. India Rhinovirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 28. India Rhinovirus Infections Drug Sales (Million USD) Growth Rate (2016-2027) Figure 29. Global 5 Largest Rhinovirus Infections Drug Players Market Share by Revenue in Rhinovirus Infections Drug: 2016 & 2020 Figure 30. Rhinovirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 31. Global Rhinovirus Infections Drug Revenue Share by Type (2016-2021) Figure 32. Global Rhinovirus Infections Drug Revenue Growth Rate by Type in 2016 & 2020 Figure 33. Global Rhinovirus Infections Drug Revenue Share by Application (2016-2021) Figure 34. Global Rhinovirus Infections Drug Revenue Growth Rate by Application in 2016 & 2020 Figure 35. North America Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 36. North America Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 37. Europe Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 38. Europe Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 39. China Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 40. China Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 41. Japan Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 42. Japan Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 43. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 44. Southeast Asia Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 45. India Rhinovirus Infections Drug Sales Market Share by Type in 2020 Figure 46. India Rhinovirus Infections Drug Sales Market Share by Application in 2020 Figure 47. Key Raw Materials Price Trend Figure 48. Manufacturing Cost Structure of Rhinovirus Infections Drug Figure 49. Manufacturing Process Analysis of Rhinovirus Infections Drug Figure 50. Rhinovirus Infections Drug Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

AIMM Therapeutics B.V. Biological Mimetics, Inc. Biota Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Johnson & Johnson Novartis AG Theraclone Sciences, Inc.